SHL Telemedicine Ltd

SHL Telemedicine Ltd(SHLT)股票分析

$2.050

-0.030 (-1.44%)收盘时

Loading chart…
High
2.100
Open
2.100
VWAP
2.04
Vol
1.68K
Mkt Cap
Low
1.975
Amount
3.43K
EV/EBITDA, TTM
0.00

SHL Telemedicine Ltd (SHL) is an Israel-based company engaged in developing and marketing personal telemedicine solutions, with a focus on cardiovascular and related diseases. Personal telemedicine is the transmission of medical data by an individual, from a remote location, to a medical call center through telecommunication networks. SHL’s platform offers solutions to subscribing patients, health insurance companies, hospitals, clinics, physicians and other health care providers. Its solutions for healthcare professionals include: CHF monitoring service that supports patients suffering from Congestive Heart Failure; COPD monitoring service that supports patients suffering from Chronic Obstructive Pulmonary Disease, and Readmission Solutions for reducing heart-related readmissions. Its consumers' solutions include Cardiac Monitoring Service.

估值指标

The current forward P/E ratio for SHL Telemedicine Ltd (SHLT) is 0.00, compared to its 5-year average forward P/E of -2.18.

Forward P/E

Fair
5Y Average P/E
-2.18
Current P/E
0.00
高估
4.24
低估
-8.60

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
高估
0.00
低估
0.00

Forward P/S

Fair
5Y Average P/S
1.23
Current P/S
0.53
高估
2.54
低估
-0.08

SHLT FAQ — answered by Alphio AI

SHL Telemedicine Ltd (SHL) is an Israel-based company engaged in developing and marketing personal telemedicine solutions, with a focus on cardiovascular and related diseases. Personal telemedicine is the transmission of medical data by an individual, from a remote location, to a medical call center through telecommunication networks. SHL’s platform offers solutions to subscribing patients, health insurance companies, hospitals, clinics, physicians and other health care providers. Its solutions for healthcare professionals include: CHF monitoring service that supports patients suffering from Congestive Heart Failure; COPD monitoring service that supports patients suffering from Chronic Obstructive Pulmonary Disease, and Readmission Solutions for reducing heart-related readmissions. Its consumers' solutions include Cardiac Monitoring Service. It operates in the Healthcare sector (OFFICES AND CLINICS OF DOCTORS OF MEDICINE industry).

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

免费开始